Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000927016-03-002223
Filing Date
2003-04-30
Accepted
2003-04-30 13:07:48
Documents
5
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K AMENDMENT NO 1 d10ka.htm 10-K/A 1075171
3 CONSENT OF ERNST & YOUNG LLP. dex231.htm EX-23.1 1846
4 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER. dex991.htm EX-99.1 2709
5 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER. dex992.htm EX-99.2 2675
6 GRAPHIC g10713g41t29.jpg GRAPHIC 79780
  Complete submission text file 0000927016-03-002223.txt   1164367
Mailing Address 125 SUMMER STREET BOSTON MA 02110
Business Address 125 SUMMER STREET BOSTON MA 02110 6179332130
POINT THERAPEUTICS INC (Filer) CIK: 0000919745 (see all company filings)

EIN.: 043216862 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-23776 | Film No.: 03671770
SIC: 3841 Surgical & Medical Instruments & Apparatus